Vowst restores gut microbiome balance using live biotherapeutic products, differing from traditional antibiotic treatments for C. difficile infections. Clinical trials showed Vowst significantly ...
Paul Feuerstadt, MD, FACG, AGAF, discusses how testing for Clostridioides difficile is recommended for hospitalized patients or outpatients with new-onset, unexplained diarrhea who have risk factors ...
A new study pinpoints certain aspects of the immune system that may play a role in the recurrence and progression of hepatitis C virus after liver transplantation. A new study pinpoints certain ...
Introduction: Data on the risk of hepatocellular carcinoma (HCC) recurrence in a transplanted liver following direct‑acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection are sparse and ...
Pattern of Rash, Diarrhea, and Hepatic Toxicities Secondary to Lapatinib and Their Association With Age and Response to Neoadjuvant Therapy: Analysis From the NeoALTTO Trial Prospective collection of ...
Fecal microbiota transfer is an effective long-term treatment for recurrent Clostridium difficile infection, according to a study in United European Gastroenterology. Researchers examined 39 patients ...
The race of liver donors may affect recurrent hepatitis C in patients after liver transplant, according to a new study. The race of liver donors may affect recurrent hepatitis C in patients after ...
Ticagrelor and aspirin is the preferred combination for reducing the risk of recurrent stroke in clopidogrel nonresponders, but according to post hoc analysis of the CHANCE-2 trial, patients with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback